Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 226

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 226
---
 he may resign at any time without any
rights to damages or compensation. Dr. Parker is also required to resign in connection with the Board of Directors determination that
his acceptance of any other employment, engagement, appointment, interest or involvement with any business or person competes or conflicts
with his appointment and would result in a serious conflict of interest or Dr. Parker reasonably determines such interest would result
in a serious conflict of interest, and Dr. Parker accepts such employment, engagement, appointment, interest or involvement, without any
rights to damages or compensation. If Dr. Parker resigns for any other reason, he must provide 12 months written notice.

Compensation of Senior Management

The following table summarizes
the compensation earned by our senior management during 2024 (including for any service on any our subsidiaries), including one former
executive officer.

| Name                                              |     | Salary 
 (£)    |         |     | Bonus  
 (£)(1) |   |     | Option        
 Awards (£)(2) |         |     | All Other    
 Compensation 
 (3)(£)       |        |     | Total 
 (£)   |         |
| Stephen Stamp                                     |     |        |         |     |        |   |     |               |         |     |              |        |     |       |         |
| Chief Executive Officer & Chief Financial Officer |     |        | 249,991 |     |        | - |     |               | 157,808 |     |              |  3,025 |     |       | 410,824 |
| Dmitry Zamoryakhin, M.D. (4)(5)                   |     |        |         |     |        |   |     |               |         |     |              |        |     |       |         |
| Former Chief Scientific Officer                   |     |        | 245,240 |     |        | - |     |               |  52,602 |     |              | 11,597 |     |       | 309,440 |
| All senior management as a group (2 persons)      |     |        | 495,231 |     |        | - |     |               | 210,410 |     |              | 14,622 |     |       | 720,264 |

_____________

| (1) | Mr. Stamp has a bonus target of 33 of his annual base salary, which bonus is payable upon attainment of                                   
 objectives as determined in the subjective